Patterson Companies Inc 's Revenue in the fiscal year 2024 $ 6,568.24 millions
Patterson Companies Inc 's Revenue in the fiscal year 2023 $ 6,471.47 millions
Patterson Companies Inc 's Revenue in the fiscal year 2022 $ 6,499.41 millions
Patterson Companies Inc 's Revenue in the fiscal year 2021 $ 5,912.07 millions
Patterson Companies Inc 's Revenue in the fiscal year 2020 $ 5,490.01 millions
PDCO Revenue third quarter 2025 Y/Y Growth Comment
Patterson Companies Inc reported decrease in Revenue in the third quarter 2025 by -2.73% to $ 1,571.82 millions, from the same quarter in 2024. The decrease in the third quarter 2025 Patterson Companies Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 5.76%.
Looking into third quarter 2025 results within Medical Equipment & Supplies industry 124 other companies have achieved higher Revenue growth. While Patterson Companies Inc ' s Revenue decline of -2.73% ranks overall at the positon no. 2465 in the third quarter 2025.
PDCO Revenue ( Y/Y Growth %)
2025
2024
2023
2022
4th Quarter
April
-
0.17 %
5.03 %
4.93 %
3rd Quarter
January
-2.73 %
0.95 %
0.27 %
2.92 %
2nd Quarter
October
1.34 %
1.59 %
-1.39 %
6.18 %
1st Quarter
July
-2.19 %
3.47 %
-5.67 %
29.62 %
FY
-
1.5 %
-0.43 %
-
Financial Statements
Patterson Companies Inc 's third quarter 2025 Revenue
Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025
Patterson Companies Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
24.67 %
1.5 %
-11.65 %
(Oct 24 2020)
PDCO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2025 Patterson Companies Inc disclosed decline in Revenue from the second quarter by -6.11% to $ 1,571.82 millions, from $ 1,674.09 millions achived in the previous reporting period.
But that's not important problem, as Patterson Companies Inc 's Revenue generally seem to plunge in this quarter.
Within Medical Equipment & Supplies industry 159 other companies have achieved higher Revenue quarter on quarter growth. While Patterson Companies Inc 's Revenue growth quarter on quarter, overall rank is 3202.
In the III. Quarter 2025 Patterson Companies Inc disclosed decline in Revenue from the second quarter by -6.11% to $ 1,571.82 millions, from $ 1,674.09 millions achived in the previous reporting period.
But that's not important problem, as Patterson Companies Inc 's Revenue generally seem to plunge in this quarter.
Within Medical Equipment & Supplies industry 159 other companies have achieved higher Revenue quarter on quarter growth. While Patterson Companies Inc 's Revenue growth quarter on quarter, overall rank is 3202.
Patterson Companies Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jan 25 2025)
12 Months Ending (Oct 26 2024)
12 Months Ending (Jul 27 2024)
12 Months Ending (Apr 27 2024)
12 Months Ending (Jan 27 2024)
Cumulative Revenue 12 Months Ending
$ 6,511.68
$ 6,555.86
$ 6,533.80
$ 6,568.24
$ 6,565.24
Y / Y Revenue Growth (TTM)
-0.82 %
0.09 %
0.15 %
1.5 %
2.76 %
Year on Year Revenue Growth Overall
Ranking
# 850
# 1587
# 1525
# 0
# 1275
Seqeuential Revenue Change (TTM)
-0.67 %
0.34 %
-0.52 %
0.05 %
0.23 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2234
# 1799
# 1605
# 0
# 1953
Cumulative Revenue growth Comment
For the 12 months ended Jan 25 2025 Patterson Companies Inc reported a decrease in Revenue by -0.82% year on year, to $6,512 millions, compare to the 0.09% growth at Oct 26 2024.
In the Healthcare sector 110 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 850, from total ranking in previous quarter at 1587.
For the 12 months ended Jan 25 2025 Patterson Companies Inc reported a decrease in Revenue by -0.82% year on year, to $6,512 millions, compare to the 0.09% growth at Oct 26 2024.
In the Healthcare sector 110 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 850, from total ranking in previous quarter at 1587.
About Patterson Companies Inc Revenue Growth Rates (PDCO), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
